Adma Biologics (ADMA) Share-based Compensation (QoQ) (2011 - 2025)
Adma Biologics (ADMA) Share-based Compensation (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.84% |
| Sep 30, 2025 | 1.69% |
| Jun 30, 2025 | 7.33% |
| Mar 31, 2025 | -14.89% |
| Dec 31, 2024 | 70.90% |
| Sep 30, 2024 | 11.04% |
| Jun 30, 2024 | 33.72% |
| Mar 31, 2024 | 22.69% |
| Dec 31, 2023 | 2.95% |
| Sep 30, 2023 | 3.54% |
| Jun 30, 2023 | 47.48% |
| Mar 31, 2023 | 3.83% |
| Dec 31, 2022 | -18.61% |
| Sep 30, 2022 | 10.28% |
| Jun 30, 2022 | -27.44% |
| Mar 31, 2022 | 35.30% |
| Dec 31, 2021 | 76.26% |
| Sep 30, 2021 | -14.52% |
| Jun 30, 2021 | 3.04% |
| Mar 31, 2021 | 13.55% |